Welcome to our dedicated page for Neogen news (Ticker: NEOG), a resource for investors and traders seeking the latest updates and insights on Neogen stock.
Neogen Corporation (NASDAQ: NEOG) provides essential solutions for food safety and animal health through advanced diagnostic technologies. This page serves as the definitive source for official company news, offering investors and industry professionals timely updates on developments impacting global food security and veterinary practices.
Access curated press releases and announcements covering financial results, product launches, strategic partnerships, and regulatory milestones. Our aggregation ensures you stay informed about NEOG's innovations in pathogen detection, molecular testing platforms, and biosafety initiatives without needing to monitor multiple sources.
All content is verified for accuracy and relevance, providing a trustworthy resource for understanding Neogen's market position and technological advancements. Key updates include progress in genomic testing, international expansion efforts, and collaborations with agricultural regulators.
Bookmark this page or check back regularly for unfiltered access to Neogen's corporate communications and critical updates that shape the future of food and animal safety industries.
Neogen Corporation (NASDAQ: NEOG) reported challenging fourth-quarter 2025 results, with revenue declining 4.8% to $225.5 million. The company recorded a significant net loss of $612.2 million, primarily due to non-cash goodwill impairment related to the 3M Food Safety Division acquisition. Adjusted Net Income was $11.3 million ($0.05 per share), while Adjusted EBITDA reached $40.6 million.
The Food Safety segment revenue decreased 3.0% to $161.8 million, while Animal Safety segment revenue fell 8.9% to $63.6 million. Gross margin declined to 41.2% from 47.9% year-over-year. For fiscal 2026, Neogen projects revenue between $820-840 million and Adjusted EBITDA of $165-175 million.
Neogen Corporation (NASDAQ: NEOG) has launched Molecular Detection Assay - Listeria Right Now™, a rapid testing solution for detecting Listeria species in environmental samples. The innovative test delivers results in approximately two hours, significantly faster than traditional methods that require 24-48 hours.
The new solution features a streamlined testing process with no enrichment required, user-friendly sampling devices for various surface types, and color-coded reagent pellets for improved workflow efficiency. The system can test up to 96 samples per run and supports simultaneous testing across multiple qualitative assays.
Neogen is showcasing the product at IAFP 2025 in Cleveland, Ohio, where food safety professionals can experience live demonstrations at Booth #511.
Neogen Corporation (NASDAQ: NEOG), a global leader in food safety solutions, has appointed Mike Nassif as its new CEO and President, effective August 11, 2025. Nassif, who will also join Neogen's Board of Directors, succeeds John Adent after his eight-year tenure.
Nassif joins from Siemens Healthineers, where he served as Global President of Point-of-Care Diagnostics, demonstrating success in driving business growth. His appointment aligns with Neogen's focus on achieving growth, profitability, and operational targets through its portfolio of food and animal safety solutions.
Neogen Corporation (NASDAQ: NEOG) has successfully completed the sale of its global cleaners and disinfectants business to Kersia Group for $130 million in cash, with additional contingent consideration based on future business performance.
The strategic divestiture aims to streamline Neogen's operations and strengthen its focus on core business activities. The company plans to utilize the net proceeds to repay $100 million of debt in the current quarter, which is expected to reduce its net leverage by approximately 0.4x on a pro forma basis.
Neogen Corporation (NASDAQ: NEOG) has scheduled its fourth-quarter earnings release for Tuesday, July 29, 2025, before market open. The company will host a conference call and webcast at 8:00 a.m. Eastern time to discuss the financial results.
Investors can access the conference call through toll-free numbers for North America (1-800-549-8228) and international callers (+1 646-564-2877) using Conference ID 65461. A replay will be available via phone and on Neogen's Investor Relations website after the call.
Neogen Corporation (NASDAQ: NEOG), a leader in food safety solutions, has announced its participation in the upcoming 45th Annual William Blair Growth Stock Conference in Chicago. David Naemura, who serves as both Chief Financial Officer and Chief Operating Officer, will deliver a presentation on June 4, 2025, at 8:40 a.m. Central Time. Interested parties can access the webcast through the Events & Presentations section of Neogen's investor relations website.
Neogen Corporation (NASDAQ: NEOG) announced a significant board transition, with James P. Tobin retiring from the Board of Directors effective May 31, 2025, after serving since 2016. Tobin currently chairs the Governance and Sustainability Committee and serves on the Audit Committee. James C. Borel, Board Chair, will temporarily lead the Governance Committee until a successor is named.
The company appointed Andrea Wainer as Tobin's replacement, effective June 1, 2025. Wainer brings over 25 years of diagnostics and healthcare industry experience, most recently serving as Executive Vice President of Rapid and Molecular Diagnostics at Abbott Laboratories. She also serves on Analog Devices' (NASDAQ: ADI) board as a member of the Nominations and Governance Committee.
Neogen (NASDAQ: NEOG) has announced the sale of its global cleaners and disinfectants business to Kersia Group for $130 million in cash, plus performance-based contingent consideration. The transaction is expected to close in Q1 of fiscal year 2026 and be margin-accretive.
The cleaners and disinfectants business, generating approximately $60 million in annual revenue, serves livestock applications including swine, poultry, and ruminants operations. The sale proceeds will be used to repay the $100 million drawn on the Company's revolving credit facility, reducing Neogen's net leverage ratio by approximately 0.4x on a pro forma basis.
This strategic divestiture allows Neogen to focus on its core food safety diagnostics business, while Kersia Group aims to leverage the acquired business's expertise and product range to enhance its global biosecurity solutions.
Neogen (NASDAQ: NEOG) announced that CEO and President John Adent will be stepping down after eight years with the company. Adent will continue in his current roles until a successor is appointed.
The Board of Directors has formed a special committee led by Board Chair Jim Borel, Thierry Bernard, and Jeff Capello to oversee the CEO search process. The company has engaged a leading global executive search firm to assist with the transition.
The committee will support the leadership team in executing ongoing strategic initiatives, including growth, profitability improvement, and portfolio prioritization. The company emphasizes its position in the food safety market with its broad portfolio of solutions and enhanced innovation capabilities.
FAQ
What is the current stock price of Neogen (NEOG)?
What is the market cap of Neogen (NEOG)?
